BSE Live
Sep 26, 16:01Prev. Close
355.85
Open Price
348.60
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Sep 26, 15:59Prev. Close
355.95
Open Price
349.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
338.90 (1451)
Balance Sheet of Biocon (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 600.30 | 600.30 | 600.30 | 600.30 | 600.00 | |
Total Share Capital | 600.30 | 600.30 | 600.30 | 600.30 | 600.00 | |
Reserves and Surplus | 10,923.20 | 10,311.10 | 10,314.80 | 7,491.70 | 7,306.20 | |
Total Reserves and Surplus | 10,924.10 | 10,312.00 | 10,315.70 | 7,492.60 | 7,307.10 | |
Total Shareholders Funds | 11,524.40 | 10,912.30 | 10,916.00 | 8,092.90 | 7,907.10 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 2,251.50 | 2,040.80 | 1,297.70 | 75.90 | 0.00 | |
Deferred Tax Liabilities [Net] | 13.60 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Long Term Liabilities | 61.10 | 95.60 | 92.80 | 83.70 | 90.10 | |
Long Term Provisions | 33.30 | 28.30 | 25.40 | 25.60 | 26.30 | |
Total Non-Current Liabilities | 2,359.50 | 2,164.70 | 1,415.90 | 185.20 | 116.40 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 619.50 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade Payables | 814.40 | 447.60 | 485.90 | 380.90 | 372.00 | |
Other Current Liabilities | 268.80 | 211.50 | 183.90 | 185.20 | 152.70 | |
Short Term Provisions | 34.50 | 32.10 | 28.20 | 24.80 | 25.50 | |
Total Current Liabilities | 1,737.20 | 691.20 | 698.00 | 590.90 | 550.20 | |
Total Capital And Liabilities | 15,621.10 | 13,768.20 | 13,029.90 | 8,869.00 | 8,573.70 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 1,045.30 | 885.40 | 882.70 | 784.30 | 708.20 | |
Intangible Assets | 14.20 | 15.00 | 16.70 | 20.40 | 20.40 | |
Capital Work-In-Progress | 686.70 | 545.00 | 328.90 | 270.30 | 164.60 | |
Other Assets | 54.00 | 58.00 | 62.00 | 65.50 | 69.50 | |
Fixed Assets | 1,814.80 | 1,518.00 | 1,304.90 | 1,155.10 | 977.30 | |
Non-Current Investments | 11,382.60 | 9,255.60 | 8,949.80 | 5,017.80 | 5,073.40 | |
Deferred Tax Assets [Net] | 0.00 | 7.40 | 22.80 | 120.00 | 146.40 | |
Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 19.00 | 0.00 | |
Other Non-Current Assets | 253.50 | 227.20 | 186.40 | 154.90 | 207.30 | |
Total Non-Current Assets | 13,450.90 | 11,008.20 | 10,463.90 | 6,466.80 | 6,404.40 | |
CURRENT ASSETS | ||||||
Current Investments | 0.00 | 62.90 | 320.90 | 262.20 | 339.30 | |
Inventories | 836.30 | 664.70 | 560.10 | 541.50 | 430.90 | |
Trade Receivables | 829.40 | 1,048.10 | 658.00 | 700.60 | 588.00 | |
Cash And Cash Equivalents | 249.80 | 585.70 | 720.30 | 689.30 | 601.20 | |
Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 22.30 | 0.00 | |
OtherCurrentAssets | 254.70 | 398.60 | 306.70 | 186.30 | 209.90 | |
Total Current Assets | 2,170.20 | 2,760.00 | 2,566.00 | 2,402.20 | 2,169.30 | |
Total Assets | 15,621.10 | 13,768.20 | 13,029.90 | 8,869.00 | 8,573.70 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 1,081.40 | 1,125.30 | 754.80 | 638.30 | 1,749.60 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 788.60 | 651.00 | 665.40 | 636.00 | 508.40 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | -- | -- | -- | -- | -- | |
Other Earnings | 890.90 | 904.30 | 1,012.10 | 888.50 | 670.70 | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | 593.47 | 593.47 | 593.47 | 593.47 | 593.47 | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | 15,428.50 | 15,475.60 | 13,096.50 | 16,871.80 | 15,346.80 | |
Non-Current Investments Unquoted Book Value | 9,377.40 | 7,185.00 | 6,878.30 | 2,359.70 | 2,411.80 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | -- | 62.90 | 320.90 | 255.00 | 205.00 |
18.09.2025
18.09.2025
11.09.2025
05.09.2025
19.08.2025
Biocon Standalone June 2025 Net Sales at Rs 537.10 crore, up 5.19% Y-o-Y
08.05.2025
Biocon Consolidated March 2025 Net Sales at Rs 4,417.00 crore, up 12.76% Y-o-Y
08.05.2025
Biocon Standalone March 2025 Net Sales at Rs 643.80 crore, up 20.88% Y-o-Y
31.01.2025
Biocon Consolidated December 2024 Net Sales at Rs 3,821.40 crore, down 3.35% Y-o-Y